References

Quit Smoking Magic

Quit Smoking Cigarette

Get Instant Access

1. Health Care, Self-Care & Self-Medication, available online at http://www.chpa-info.org/ international/Health_care,asp, accessed June 11,2001.

2. Self-Care in the New Millennium: American Attitudes Toward Maintaining Personal Health and Treatment, available online at http://www.chpa-info.org, accessed June 11, 2001.

3. Access to Self-Care: The Revolution is Here!, available online at http://www.aesgp.be, accessed on August 6,2001.

4. R. Eichner and T. J. Maronick, J. Pharm. Market. Manage, 13, 19 (2001).

5. M. S. Wilkes, R. A. Bell, and R. L. Kravitz, Health Affairs, 19,110 (2000).

8. S. H. McNamara, Food Drug Law J., 54, 35 (1999).

9. Q. Bryan, L. K. Coleman, S. M. Meisberger, and T. Copmann, Drug Info.J.,35,529 (2001).

12. S. H. McNamara, J. Nutraceut. Funct. Med. Foods, 3, 45-78 (2000).

14. A P. M. Lavrijsen and B. J. Vermeer, Br. J. Dermatol., 124,503 (1991).

15. W. Harth and R. Linse, Int. J. Clin. Pharmacol. Ther., 39,484 (2001).

17. T. R. Covington in L. V. Allen Jr, Ed., Handbook of Nonprescription Drugs, 12th ed.,

American Pharmaceutical Association, Washington, DC, 2000, pp. 3-14.

20. R. P. Brady and K. L. Kelley, Cosmetics Toiletries, 105, 57 (1990).

23. P. B. Hutt, Food Drug Cosmetic Law J., 37, 427 (1982).

24. W. E. Gilbertson, Handbook of Nonprescription Drugs, 9th ed., American Pharmaceutical Association, Washington, DC, 1990, pp. 25-39.

25. W. E. Gilbertson, Drug Inform. J., 19, 101 (1985).

27. W. E. Gilbertson, S. A. Francesco in R. A. Gua-rina, Ed., New Drug Approval Process-The Global Challenge, 3rd ed., Marcel Dekker, Inc., New York, 2000, pp. 375-391.

28. OTC Review Summary, available online at http://www.chpa-info.org/issues/OTC_Review-_Summary.asp, accessed on June 14,2001.

29. Federal Register, 67,3060-3076 (2002).

31. K. J. Kraushaar, Food Drug Cosmetic Law J., 54,243 (1999).

32. G. J. Mossinghoff, Food and Drug Law J., 54, 187 (1999).

36. P. H. Rheinstein, Drug Inform. J., 19, 139 (1985).

39. 21 Code of Federal Regulations, Part 330 Section 10(4) (i), Office of the Federal Register, National Archives and Records Administration, Washington DC, April 1,2001.

40. Federal Register 55: 27776-27784, Office of the Federal Register, National Archives and Records Administration, July 5 1990.

41. 21 Code of Federal Regulations, Part 330 Section 10(4) (ii), Office of the Federal Register, National Archives and Records Administration, Washington DC, April 1,2001.

42. 21 Code of Federal Regulations, Part 201 Section 66(c) (5), Office of the Federal Register, National Archives and Records Administration, Washington DC, April 1,2001.

44. 21 Code of Federal Regulations, Part 201 Section 66, Office of the Federal Register, National Archives and Records Administration, Washington DC, April 1,2001.

45. Deregulation 2001: The Future of Medicine Regulation in Europe, available on http://www.

accessed on

August 6, 2001.

48. Review of the Process for Reclassification (Change of Legal Status) of Medicines in the UK, available online at http://www.mca.gov. uk/home.htm, accessed on December 19,2001.

49. Nonprescription Drugs—Value of a Pharmacist-Controlled Class Has Yet to Be Demonstrated (Chapter Report, 08/24/95, GAO/ PEMD-95-12),available online at, www.gao.gov, accessed on December 28,2001.

50. Pharmaceutical Administration and Regulations in Japan, available online at http://

accessed on August 3,2001.

51. Current Issues, available online at http://www. otc.gr.jp/english/guide/g04.html, accessed on August 3,2001.

52. Pharmaceutical Affairs, available online at http://www.otc.gr.jp/english/guide/g02.html, accessed on August 3,2001.

53. K. Danjoh and H. Kumagai, Proceedings of The Association of the European Self-Medication Industry (AESGP) 35th Annual Meeting, Berlin, June 9-12,1999.

54. J. Weber, The New Era of Lifestyle Drugs, available online at http://www.businessweek. com/1998/19/b3577001.htm, accessed on December 28,2001.

55. P. Coy, Commentary: Is This Prescription Necessary?, available online at http://www. businessweek.com/1998/19/b3577007.htm, accessed on December 28, 2001.

56. R. Herman, International Herald Tribune, November 18,1998,pp. 21.

61. D. Reissman, Dis. Manage. Health Outcomes, 6,249 (1999).

62. D. Gilbert, Lifestle Drugs: Who Will Pay?, Scrip Report, PJB Publications, London, 1999.

63. D. Gilbert, T.Walley, and B. New, BMJ, 321, 1341-1344 (2000).

64. H. Gerhard, Int. J. Clin. Pharmacol. Ther.,39, 362 (2001).

65. B. Brosig, J. Kupfer, V. Niemeier, and U. Gieler, Int. J. Clin. Pharmacol. Ther.,39,279 (2001).

66. W .Harthand R. Linse,/rcf. J. Clin.Pharmacol. Ther., 39,460 (2001).

67. H. A Wieland and B. S. Hamilton, Int. J. Clin. Pharmacol. Ther., 3 9,4 0 6 (2001).

68. W.H arth and R. Linse, Int. J. Clin. Pharmacol. Ther., 39,284 (2001).

69. Med Ad New staff, Med. Ad. News, 19, 52 (2000).

75. J. Van Der Donk, J. Passchier, G. M. Dutree-Meulenberg, E. Stolz, and F. Verhage, Int. J. Dermatol., 30, 22 (1991).

77. J. S. Storer, J. Brzuskiewicz, H. Floyd, and J. C. Price, Am. J. Med. Sei., 291,328 (1986).

78. T. F. Cach, V. H. Price, and R. C. Savin, J. Am. Acad. Dermatol., 29,568 (1993).

79. J. Van der Donk, J. Passchier, C. Knegt-Junk, et al., Br. J. Dermatol., 125,248(1991).

80. P. Moghetti, R. Castello, C. M. Magnani, et al., J. Clin. Endocrinol. Metab., 79,1115 (1994).

81. L. Falsett and A Gambera, Fertil. Steril.,12, 41 (1999).

82. A. R. Diani, M. J. Mulholland, K. L. Shull, et al., J. Clin. Endocrinol.Metab., 74,3 4 5(1992).

83. L. Rhodes, J. Harper, H. Uno, et al., J. Clin. Endocrinol. Metab. ,79,991 (1994).

84. M. Sommer and C. Wilson, Int. J. Clin.Pradt., 53,381(1999).

85. F. H. Leenen, D. L. Smith, and W. P. Unger, Br. J. Clin. Pharmacol., 26,4 81(1988).

86. K.J. Mclellan and A. Markham, Drugs, 57, 111 (1999).

87. M. G. Eller, G. J. Szpunar, and A A Della-Coletta, Clin. Pharmacol. Ther., 45, 396 (1989).

89. J.J. Ferry, J. H. Shepard, and G. J. Szpunar, J. Pharm. Sei., 7 9,483(1990).

90. R. S. Rittmaster, N. Eng. J. Med., 330, 120 (1994).

91. S. Murad, M. C. Tennant, and S. R. Pinnell, Arch. Biochem. Biophys, 292,234(1992).

92. G. H. Rasmusson, G. F. Reynolds, N. G. Steinberg, et al., J. Med. Chem.,29,2298(1986).

93. The Physicians' Desk Reference,(2001).

94. M. Brandt, A. T. Greway, D. A. Holt, B. W. Metcalf, and M. A. Levy, J. Steroid Biochem. Mol. Biol., 37,575 (1990).

95. A. Guarna, E. G. Occhiato, G. Danza,A. Conti, and M. Serio, Steroids, 63,355 (1998).

96. M. L. Moss, P. Kuzmic, J. D. Stuart, et al., Biochemistry, 35,3457 (1996).

97. T. N. Mellin, R. D. Busch, and G. H. Rasmus-son, J. Steroid Biochem. Mol. Biol., 44, 121 (1993).

98. M. E. Sawaya and J. Shapiro, Dermatol. Clinics, 18, 47 (2000).

99. J. Shapiro and V. H. Price, Dermatol. Clinics, 16,341 (1998).

100. R. C Wester, H. I. Maibach, R. H. Guy, and E. Novak, J. Invest. Dermatol, 82, 515 (1984).

101. J. T. Headington, Dermatologica, 175, 19 (1987).

102. C. N. Falanyand E. A. Kerl, Biochem. Pharmacol, 40,1027 (1990).

103. K. D. Meisheri and L. A. Cipkus, Dermatologica,. 175, 3 (1987).

104. K. D. Meisheri, L. A. Cipkus, and C. J. Taylor, J. Pharmacol. Exp. Ther., 245, 751 (1988).

105. K. Takeshita, I. Yamagishi, T. Sugimoto, S. Otomo, and K. Moriwaki, Ann. NY Acad, Sci, 642,470 (1991).

106. Y. Mori, T. Hamamoto, and S. Otomo, Ann. NY Acad. Sci, 642,473 (1991).

107. S. Ahmed and S. Denison, Bioorg. Med. Chem. Lett,8,409 (1998).

108. E. Stoner, J. Steroid Biochem. Mol. Biol., 37, 375 (1990).

109. R. K. Bakshi, G. H. Ramusson, G. F. Patel, et al, J. Med. Chem, 38,3189 (1995).

110. S. V. Frye, C D. Haffner,and P. R. Maloney, J. Med. Chem, 38,2621 (1995).

112. T. B. Gottlieb, F. H. Katz, and C. A. Chidsey, Circulation, 45, 571 (1972).

113. B. Amichai, M H. Grunwald, and R. Sobel, Int. J. Dermatol, 36,182 (1997).

114. V. A. Randall, Bailliere's Clin. Endocrinol. Metab., 8,405 (1994).

115. FDC Reports—The NDA Pipeline, available online at www.ndapipeline.com, accessed on July 6,2001.

116. R&D Focus, IMS Publications, London, available at http://lifecycle.imshealth.camaccessed on July 12, 2001.

117. H. Padma-Nathan, Am. J. Cardiol, 84, 18N (1999).

118. H. A. Feldman, I. Goldstein, D. G. Hatzichris-tou, R. J. Krane, and J. B. McKinlay, J. Urol, 151, 54 (1994).

119. A Morales, Int. J. Impotence Res., 12, S80 (2000).

120. A. Reading and W. Weist, Arch. Sex Behav., 13, 69 (1984).

121. S. Read, M. King, and J. Watson, J. Public Health Med, 19, 387 (1997).

122. J. R. Berman, L. Berman, and I. Goldstein, Urology, 54, 385 (1999).

123. E. O. Laumann, A. Paik, and R. C. Rosen, JAMA, 281,537 (1999).

124. Recommendations of the 1st International Consultation on Erectile Dysfunction (July, 1999), available online at http://www.issir.org/

accessed on June 13,2002.

125. H.D. Langtry and A Markham, Drugs, 57,967

126. R. G. Manecke and J. P. Mulhall, Ann. Med, 31,388 (1999).

127. A. T. Guay, J. B. Perez, E. Velasquez, R. A. Newton, and J. P. Jacobson, Eur. Urol., 38, 671 (2000).

129. M P. Cary and B. T. Johnson, Arch. Sex Behav, 4,341 (1996).

130. E. Ernst and M. H. PittlerJ. Urol, 159, 433 (1998).

131. K. Reid, D. H. Surridge, A. Morales, and J. Fenemore, Lancet, 2,421 (1987).

132. A. J. Riley, Br. J. Clin. Pharmacol, 48, 133 -(1994).

133. The American Urological Association Erectile Dysfunction Clinical Guidelines Panel, The Treatment of Organic Erectile Dysfunction, 1996, available online at http://shop.auanet. org/timssnet/products/clinical_guidelines/ed. pdf, accessed on September 18,2001.

135. 0.1. Linet and F. G. Ogrinc, N. Eng. J. Med, 334,873 (1996).

136. S. K. Guthrie, M. Hariharan, and L. J. Grun-haus, Eur. J. Clin. Pharmacol, 39,409 (1990).

137. P. Le Corre, G. Dollo, F. Chevanne, and R. Le Verge, Eur. J. Pharm. Sci, 9, 79 (1999).

138. J. A. Owen, S. L. Hakatsu, J. Fenemore, et al, Eur J. Clin. Pharmacol, 32, 577 (1987).

139. A. K. S. Ho, D. B. Hoffman,S. Gershon, and H. H. Loh, Arch. Int. Pharmacodyn. Ther., 194, 304 (1971).

140. T. J. Bivalacqua, H. C. Champion, W. J. G. Hellstrom, and P. J. Kadowitz, Trends Pharmacol Sci, 21,484 (2000).

141. M. Maggi, S. Filippi, F. Ledda, A. Magini, and G. Forti, Eur. J. Endocrinol., 143 (2002).

143. S. A. Ballard, C. J. Gingell, K. Tang, L. A Turner, M. E. Price, and A.M. Naylor, J. Urol, 159,2164 (1998).

144. J. T. Clark, E. R. Smith, and J. Mi. Davidson, Science, 255,847 (1984).

145. J. T. Clark, E. R. Smith, and J. M. Davidson, Neuroendocrinology, 41, 36 (1985).

146. J. T. Clark, Neuropharmacology, 30, 373 (1990).

147. A.M. Traish, R. B. Moreland, Y. H. Huang, and J. Goldstein, Recept. Signal Transduction, 7, 55 (1997).

148. T. J. Feuerstein, G. Hertting, and R. Jackisch, Naunyn Schmiedebergs Arch. Pharmacol., 329,216 (1985).

149. N. K. Terrett, A. S. Bell, D. Brown, and P. Ellis, Bioorg. Med. Chem. Lett., 6, 1819 (1996).

150. D. P. Rotella, Z. Sun, Y. Zhu, et al., J. Med. Chem., 43, 1257 (2000).

151. D-K. Kim, N. Lee, J. Y. Lee, et al., Bioorg Med. Chem., 9, 1609 (2001).

152. D-K Kim, D. H. Ryu, N. Lee, et al., Bioorg. Med. Chem., 9, 1895 (2001).

153. D-K Kim, J. Y. Lee, N. Lee, et al., Bioorg. Med. Chem, 9,3013 {2001).

154. A. Hunter, A Practical Treatise on Disorders of the Sexual Function of the Male and Female, FA Davis, Philadelphia, PA, 1926.

155. R. T. Segraves, H. W. Schoenberg, C. K. Zarins, et al, Psychosom. Med, 43,227 {1981).

157. G. S. Brindley, Br. J. Psychiatry, 143, 332 (1983).

158. NIH Consensus Development Panel on Impotence, JAMA, 270, 83 (1998).

159. E. Palmer, Making the Love Drug, available online at www.chemsoc.org/chembytes/ezine/ 1999/viagra.htm, accessed on June 11,2001.

160. I. M. Iribarren and I. S. de Tejada, Curr. Opin. Urol, 9,547 (1999).

161. Melanotan Information, available online at http://www.melanotan.org/botwin.html, accessed on July 23, 2001.

162. Palatin Technologies Press Release May 30, 2002, available online at http://biz.yahoo.com/ bw/020530/302057_2.html, accessed on July 23, 2002.

163. Center for the Disease Control and Prevention, A Report ofthe Surgeon General —2000,

Reducing Tobacco Use, available online at www.cdc.gov/tobaco/sgr/sgr_2000, accessed on July 23,2002.

164. Center for Disease Control and Prevention, MMWR Morb. Mortal. Wkly. Rep., 48, 993 (1999).

165. Center for Disease Control, MMWR Morb. Mortal. Wkly. Rep, 45,588 (1996).

166. W. Velicer, J. Fava, and J. Prochaska, et al., Prevent. Med, 24,401 (1995).

167. Smoking Cessation Clinical Practice Guideline Panel and Staff,JAMA, 275,1270 (1996).

169. R. D. Hurt, D. L. Sachs, E. D. Glover, et al, N. Engl. J. Med, 337,1195 (1997).

170. L. S. Covey, M. A. Sullivan, J. A. Johnston, A. H. Glassman, M. D. Robinson, and D. P. Adams, Drugs, 59, 17 (2000).

171. J. R. Hughes, M. G. Goldstein, R. D. Hurt, et al, JAMA, 281, 72 (1999).

172. M. Kor nitzer, M. Boutsen, M. Dramabc, et al. Prevent. Med, 24, 41 (1995).

173. P. Puska, H. J. Korhonem, E. Bartiainem, et al, Tobaco Control, 4,231 (1995).

174. T. Blondal, D. Ludvikstottir, L. Gudmunds-son, et al, BMJ, 318,285 (1999).

175. D. E. Jorenby, S. J. Leischow, M. A Nides, et al, N. Engl. J. Med, 340,685 (1999).

176. M. G. Goldstein, J. Clin. Psychiatry, 59, 66 (1988). .

177. U.S. Department of Health and Human Services, Surgeon General, The Health Consequences of Smoking: Nicotine Addiction, Publication 88-8406, Center for Disease Control, Atlanta, GA, 1998.

178. J. Henningfield, C. Cohen, and W. Pickworth in CT Odeans and J. Slade, Eds, Nicotine Addiction: Principles and Management, Oxford University Press, New York, 1993, pp. 24-45.

179. J. Hughes and D. Hatsukami, Int. J. Smoking Cessation, 1, 21 (1992).

180. J. Hughes, S. Higgins, D. Hatsukami in L. Koz-lowski, H. Annis, H. Cappell, et al, Eds, Recent Advances in Alcohol and Drug Problems, vol. 101, Plenum, NewYork, 1990, pp. 317-398.

181. L. C. Dale, J. O. Ebbert, J. T. Hays, and R. D. Hurt, Mayo Clinic Proc, 75, 1311 (2000).

182. M. G. Goldstein, J. Clin. Psychiatry, 59, 66 (1998).

183. D. R. Laurence, P. N. Bennet, and M. J. Brown, Clinical Pharmacology, 8th ed, Churchill "Livingstone, New York, 1997, pp. 159-166.

184. R. Panchagnula, A Kumar Jain, and O. Pillai, Methods Find Exp. Clin. Pharmacol., 22, 299 (2000).

185. J. R. T. Davidson and K. M. Connor, J. Clin. Psychiatry, 59, 25 (1998).

186. J. A Ascher, J. 0. Cole, J-N Colin, et al., J. Clin. Psychiatry, 56, 395 (1995).

187. 0. F. Pomerleau, Am. J. Med., 93(1a), 2s (1992)

188. 0. Pomeraleau and C. Pomeraleau, Neurosci. Behav. Rev., 8,503 (1984).

189. R. Spanagel and F Weiss, TINS, 22, 521 (1999).

190. G. F. Coob, Trends Pharmacol. Sci., 13, 177 (1992).

194. G. FA Chiara, J. Psychopharmacol., 12, 54 (1998).

195. Wonnacott, L. Soliakov, G. Wilkie, P. Redfern, and D. Marshall, Drug Dev. Res. ,38,149 (1996).

196. M. W. Holladay, M. J. Dart, and J. K. Lynch, J. Med. Chem., 40,4169 (1997).

197. T. C. Westfall and D. A Brose, Biochem. Pharmacol., 20,1627 (1971).

198. I. P. Stolerman, R. Fink, and M. E. Jarvik,Psy-chopharmacology, 30,329 (1973).

199. J. Yeomans, G. Forster, and C. Blaha, Life Sci., 68, 2449 (2001).

gins, Psychopharmacology (Berl.), 157, 292 (2001).

201. I. P. Stolerrnan, P Bunker, and ME Jarvik, Psychopharmacologia, 34,317 (1974).

202. M. i. Damaj, S. P. Welch, and B. R. Martin, J. Pharmacol. Exp. Ther., 277, 454-461 (1996).

203. S. Cheeta, E. E. Irvine, P. J. Kenny, and S. E, Fille, Psychopharmacology, 155, 78 (2001).

204. M D. Aceto, H. Awaya, B. R. Martin, and E. L. May, Br. J. Pharmacol., 79,869 (1983).

205. M. D. Aceto, R. S. Bagley, W. L. Dewey, T-C Fu, and B. R. Martin, Neuropharmacology, 25, 1031 (1986).

206. M. I. Damaj, R. A. Glennon, and B. R. Martin, Brain Res. Bull., 33, 199 (1994).

207. J. A Daniand S. Heinemann, Neuron, 16,905 (1996).

208. J. E. Slemmer, B. R. Martin, and M. I. Damaj, J. Pharmacol. Exp. Ther, 295, 321 (2000).

209. C. Gotti, E. Carbonnelle, M. Moretti, R. Zwart, and F. Clementi, Behav. Brain Res., 113, 183 (2000).

210. L. P. Dwoskin and P. A. Crooks, J. Pharmacol. Exp. Ther, 298,395 (2001).

212. D. L. Musso, N. B. Mehta, F. E. Soroko, R. M. Ferris, E. B. Hollingsworth, and B. T. Kenney, Chirality, 5,495 (1993).

214. U.S. Department of Health and Welfare, Smoking and Health. Report of the Advisory Committee to the Surgeon General ofthe Public Health Service. Public Health Service Publication No 1103, 1964.

215. L. S. Covey, A. H. Glassman, and F. Stetner, Comp. Psychiatry, 31, 350 (1990).

216. L. H. Ferry, A. S. Robbins, P. D. Scariati, et al., Circulation, 86, I671 (1992).

218. E. M. Sellers, H. L. Kaplan, and R. F. Tyndale, Clin. Pharmacol. Ther., 68,35 (2000).

219. AAPS Pharmaceutica News, available online at http://www.aapspharmaceuticacomlNews2/

dnd.asp?ID=60820, accessed on July 30,2002.

220. Pharmaprojects, PJB Publications, Richmond, UK available online at http://www.datastarweb. com, accessed on July 12,2001.

221. American Cancer Society Cancer Referenceln-formation, available online at http://www. . cancer.org/eprise/main/docroot/lrn, accessed on July 27,2002.

222. American Cancer Society, available online at http://www.cancer.org/statistics/index.html. 2002 accessed on July 27,2002.

223. C. Augustin, C. Collombel, and O. Damour, Photochem. Photobiol., 66,853 (1997).

224. F. P. Gasparro, Environ. Health Perspect., 108(S1), 71 (2000).

227. C. G. Hayden, M. S. Roberts, and H. A. Benson, Aust. NZJ. Med., 28,639 (1998).

228. D. C. Steinberg, Cosmetics Toiletries Mag., Ill, 77 (1996).

229. Z. Draelos, Cosmetics in Dermatology, 2nd ed., Churchill Livingston, NewYork, NY, 1995, pp. 233-243.

230. S. Schauder and H. Ippen, Hautarzt., 39, 435 (1988).

231. G. M. Murphy, Photodermatol. Photoimmu-nol. Photomed., 15, 34 (1999).

232. C. G. Hayden, H. A. E. Benson, and M. S. Roberts in M. S. Roberts and K. A. Walters, Eds. Dermal Absorption and Toxicity Assessment, Marcel Dekker, New York, 1998, pp. 537-242.

233. A Chetelat, S. Albertini, H. H. Dresp, R. Stro-bel, and E. Gocke,Mutat. Res., 292,241 (1993).

234. J. Knowland, E. A. McKenzie, P. J. McHugh, and N. A. Cridland, FEBS Lett., 324, 309 (1993).

235. P. J. McHugh and J. Knowland, Photochem. Photobiol., 66,276(1997).

236. A.M. Bonin, A. P. Arlauskas, D. S. Angus, RSU Baker, C. H. Gallagher, G. Greenoak, M. M. Lane Brown, K. M. Meher-Homji, and V. Reeve,Mutat. Res., 105, 303 (1982).

237. F. P. Gasparro, M. Mitchnick, and J. F. Nash, Photochem. Photobiol., 68,243 (1998).

238. C. G. I. Hayden, M. S. Roberts, and H. A. E. Benson, Lancet, 350,863(1997).

239. R. Jiang, M. S. Roberts, D. M. Collins, and H. A. E. Benson, Br. j. Clin. Pharmacol., 48, 635 (1999).

240. H. A. E. Benson, Am. J. Clin. Dermatol., 1,217 (2000).

241. R. L. Bronaugh and H. I. Maibach, Eds. Percutaneous Absorption. Drugs-Cosmetics-Mechanisms-Methodology, 3rd ed., Marcel Dekker, New York, 1999, pp. 861-877.

242. R. Jiang, M. S. Roberts, D. M. Collins, and H. A. E. Benson in K. R. Brain, V. J.James, and K. A. Walters, Eds. Perspectives in Percutaneous Penetration, vol. 5b, STS Publishing, Cardiff, UK, 1997, pp. 239-241.

243. C. G. J. Hayden, N. Hoffmann, M. S. Roberts, and H.A. E. Benson in K. R. Brain, V.J.James, and K. A. Walters, Eds., Perspectives in Percutaneous Penetration, vol 5b, STS Publishing, Cardiff, UK, 1997, pp. 236-238.

244. K. A Walters, K. R. Brain, D. Howes, V. J. James, A. L. Kraus, etal., Food Chem. Toxicol., 35,1219 (1997).

245. G. M. Lazar, A. Baillet, A. E. Arnaud-Bat-tandier, D. Ferrier, J. P. Marty, Drug Cosmet. Ind., 158, 50 (1996).

246. V. K. Gupta and J. L. Zatz, J. Cosmet. Sci., 50, 79 (1999).

247. G. E. Kenney, A Sakr, J. L. Lichtin, H. Chou, and R. L. Bronaugh, J.Soc. Cosmet. Chem., 46, 117 (1995).

248. P. Treffeland B. Gabard,Pharm. Res., 13,770 (1996).

249. a. Arancibia, G. Borie, E. Cornwell, et al., Farmaco. Edu. Prat, 36,3 57 (1981).

250. R. Feldman and H. I. Maibach, J. Invest. Dermatol., 54,399 (1970).

251. G. Potard, C. Laugel, A. Baillet, H. Schaefer, and J-P Marty, Int. J. Pharm., 189,249 (1999).

252. F. Benech-Kieffer, P. Wegrich, R. Schwarzenbach, G. Klecak, T. Weber, J. Leclaire, and H. Schaefer, Skin Pharmacol. Appl. Skin Physiol., 13,324(2000).

253. C. R. Taylor, R. S. Stern, J. J. Leydenm, and B. A. Glichrest, J. Am. Acad. Dermatol., 22,1 (1990).

254. C. Fernandez, F. Nielloud, R. Fortune, L. Vian, and G. Mari-Mestres, J. Pharm. Biomed. Anal., 28,57 (2002).

255. P. Treffel and B. Gabard in K. R. Brain, V. J. James, K. A. Walters, Eds., Prediction of Percutaneous Penetration, STS Publishing, Cardiff, UK, 1996, pp. 178-181.

256. F. Pflücker, V. Wendel, H. Hohenberg, et al., Skin Pharmacol. Appl. Skin Physiol., 14(S1), 92 (2001).

257. S. M. El Dareer, J. R. Kalin, K. F. Tillery, and D. Hill, J, Toxicol. Environ. Health., 19, 491 (1986).

258. C. S. Okereke and M. S. Abdel-Rahman, Toxic Substances J.,13,239(1994).

259. J. Hany and R. Nagel, Deutsche LebensmittelRundschau, 91,341 (1995).

260. R. W. Gange in T. B. Fitzpatrick, AZ Eisen, and K. Wolff, et al., Eds., Dermatology in General Medicine, 3rd ed., McGraw Hill, New York, 1987, pp. 1451-1457.

261. N. J. Lowe and J. Friedlander in N. J. Lowe, N. A. Shaath, and M. A. Pathak, Eds., Sunscreens: Development, Evaluation, and Regulatory Aspects, 2nd ed., Marcel Dekker, New York, 1997, pp. 35-58.

262. F. Daniels, J. C. van der Leun, and B. E. Johnson, Sci. Am. 219, 38 (1968).

263. C. Routaboul and A. Denis, Eur. J.Dermatol, 9, 95 (1999).

264. B. a. Gilchrest, Br. J. Dermatol., 135, 867 (1996).

265. R. M. Lavker, G. F. Gerberick, D. Veres, C. J. Irwin, and K. H. Kaidbey, J.Am. Acad. Dermatol., 32, 53(1995).

266. R. M. Lavaker, D. A. Veres, C. J. Irwin, and K. H. Kaidbey, Photochem. Photobiol., 62,348 (1995).

267. N. J. Lowe, D. P. Meyers, J. M. Wieder, D. Luftman, T. Borget, M. D. Lehman, A. W. Johnson, and I. R. Scott, J. Invest. Dermatol., 105, 739 (1995).

268. G. J. Fisher, Z. Wang, S. C. Datta, J. Varani, S. Kang, and J. Voorhees, N. Engl. J. Med, 337, 1419 (1997).

269. J. A. Leman, Arch. Dermatol, 137, 1239 (2001).

270. P. P. Vitaliano and F. Urbach, Arch. Dermatol, 116, 454 (1980).

271. C.C. Long and R. Marks, J. Am. Acad. Dermatol, 33, 658 (1995).

272. F. Urbach, D. B. Rose, and M. Bonnem, Environment and Cancer, William & Wilkins Co, Baltimore, MD, 1972, pp. 355-371.

273. D.J. Hunter, G. A. Colditz, M. J. Stampfer, B. Rosner, W. C. Willett, and F. E. Speizer, Ann. Epidemiol, 1,13 (1990).

274. H. Silverstone and J. H. A. Searle, Br. J. Cancer, 24, 235 (1970).

Was this article helpful?

0 0
The Smoker's Sanctuary

The Smoker's Sanctuary

Save Your Lungs And Never Have To Spend A Single Cent Of Ciggies Ever Again. According to a recent report from the U.S. government. Centers for Disease Control and Prevention, more than twenty percent of male and female adults in the U.S. smoke cigarettes, while more than eighty percent of them light up a cigarette daily.

Get My Free Ebook


Post a comment